Rein Therapeutics, Inc. (RNTX): Nasdaq/NYSE listing notice — Aileron receives Nasdaq deficiency notice for missing annual meeting; appoints Marcum as auditor

Rein Therapeutics, Inc.

Received Nasdaq notice on Jan 4, 2024 for failing to hold annual meeting within 12 months after FY2022 end.
Must submit compliance plan by Feb 20, 2024; Nasdaq may grant extension to June 28, 2024.
Appointed Marcum LLP as independent auditor for FY2023, effective Jan 9, 2024.
No prior consultations with Marcum or disagreements with prior auditor reported.

item 3.01 item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Rein Therapeutics, Inc. engaged Marcum LLP as its auditor.

Action: engagement
Auditor: Marcum LLP

Exact text from the filing

On January 10, 2024, the Audit Committee of the Board of Directors of the Company appointed Marcum LLP ("Marcum") as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2023. The Company formally engaged Marcum on January 9, 2024.

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Rein Therapeutics, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a)

Exact text from the filing

January 4, 2024, Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company failed to hold its annual meeting of shareholders within twelve (12) months after its fiscal year ended December 31, 2022, as required by Nasdaq Listing Rule 5620(a) (the “Annual Meeting Listing Rule”). The Notice does not result in the immediate delisting of the Company’s common stock from the Nasdaq Capital Market. The Notice states that the Company has 45 calendar

View on SEC.gov

Browse all auditor changes →

Rein Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-005933

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.